Search Results 81-90 of 18144 for peptide therapy

  1. Gastric Bypass (Roux-En-Y) Clinical Trials - Mayo Clinic Research

    - infused at rates of 300pmol/kg/min. Given that gastrointestinal transit is typically delayed by Glucagon-Like Peptide-1 (GLP-1) and also that this hormone ...

  2. Patients receiving lutetium Lu 177 dotatate radiation therapy may experience travel delays - Mayo Clinic

    Radiation used in peptide receptor radionuclide therapy could be detected by sensitive radiation detectors at U.S. ports of entry, including international ...

  3. Rheumatoid arthritis - Diagnosis and treatment - Mayo Clinic

    This may show a higher level of inflammation in the body. Other blood tests look for rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) ...

  4. SARS-CoV-2 - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    Each identified peptide is then evaluated to ... The results from these studies will help develop peptide ... Learn about the diagnosis and treatment of COVID-19.

  5. Clinical trials - Oncology (Medical)

    ... peptide receptor radionuclide therapy (PRRT) to the usual approach of treatment with everolimus in patients who have previously received 177Lu-DOTATATE for ...

  6. A Study Of The Safety And Effectiveness Of Chronic Subcutaneous CD-NP For Renal Blood Vessel Protection For Patients Who Have Heart Failure And An LVAD - Mayo Clinic

    ... treatment works better than the current standard therapy. ... peptide (hormone) designed here at Mayo Clinic ... therapy only); Willing to provide ...

  7. Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...

  8. Daniel J. McCormick, Ph.D. - Mayo Clinic Faculty Profiles

    ... treatment. The MCPC is a ... McCormick has worked on the design and development of new natriuretic peptide (NP) drugs for the treatment of heart failure.

  9. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

    Treatment will be administered as a consolidation therapy beginning within one year of the last administration of platinum. Participation eligibility.

  10. Vector Targeting and Purification - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    Although several capsid proteins have been reported to tolerate the genetic fusion of foreign peptides and proteins, direct comparison of cell targeting ...